Literature DB >> 3271070

Structure of 3-isoadenosine.

S Kumar1, S R Wilson, N J Leonard.   

Abstract

3-beta-D-Ribofuranosyladenine, C10H13N5O4, Mr = 267.25, orthorhombic, P2(1)2(1)2(1), a = 13.470 (4), b = 16.054 (6), c = 5.141 (2) A, V = 1111.8 (7) A3, Z = 4, Dx = 1.596 g cm-3, lambda(Mo K alpha) = 0.71073 A, mu = 1.18 cm-1, F(000) = 560, T = 298 K, R = 0.043, wR = 0.042 for 1136 reflections. The tautomeric form present in the crystal is 6-NH2. The adenine moiety is nearly planar and the torsional angle of the glycosidic linkage O(4')-C(1')-N(3)-C(4) is -161.5 degrees. All N and O atoms except N(3) and O(4') participate in a three-dimensional hydrogen-bonding system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3271070     DOI: 10.1107/s0108270187011144

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  3 in total

1.  "Reverse" carbocyclic fleximers: synthesis of a new class of adenosine deaminase inhibitors.

Authors:  Sarah C Zimmermann; Joshua M Sadler; Peter I O'Daniel; Nathaniel T Kim; Katherine L Seley-Radtke
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2013       Impact factor: 1.381

2.  Which 3-ribofuranosyl-substituted purine 5'-phosphates undergo template-directed oligomerization?

Authors:  A R Hill; S Kumar; V D Patil; N J Leonard; L E Orgel
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

Review 3.  The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.

Authors:  Katherine L Seley-Radtke; Mary K Yates
Journal:  Antiviral Res       Date:  2018-04-10       Impact factor: 10.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.